2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
US-12522594-B2 · Jan 13, 2026 · US
This page is not indexed by search engines while we improve data quality.
Platten Michael patents
Platten Michael is listed as an inventor on 22 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Platten Michael |
| Total patents | 22 |
| First publication | Jan 22, 2015 |
| Latest publication | Jan 13, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
T cell receptor derived binding polypeptides
US-2025277013-A1 · Sep 4, 2025 · US
Antigen reactive t-cell receptors
US-2025270640-A1 · Aug 28, 2025 · US
2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
US-2024294505-A1 · Sep 5, 2024 · US
2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
US-11795164-B2 · Oct 24, 2023 · US
Histone anti-cancer vaccines
US-11767352-B2 · Sep 26, 2023 · US
2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
US-2023121195-A1 · Apr 20, 2023 · US
[1,2,4]triazolo[1,5-c]quinazolin-5-amines
US-2023113037-A1 · Apr 13, 2023 · US
3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides
US-11591311-B2 · Feb 28, 2023 · US
2-phenylpyrimidine-4-carboxamides as AHR inhibitors
US-11524944-B2 · Dec 13, 2022 · US
Recent patents
Latest publications not already listed above.
Sulphur substituted 3-oxo-2,3-dihydropyridazine-4-carboxamides
US-11459312-B2 · Oct 4, 2022 · US
2-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor antagonists
US-11304946-B2 · Apr 19, 2022 · US
3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides
US-11040035-B2 · Jun 22, 2021 · US
Histone anti-cancer vaccines
US-2020377562-A1 · Dec 3, 2020 · US
Sulphur substituted 3-oxo-2,3-dihydropyridazine-4-carboxamides
US-2020299269-A1 · Sep 24, 2020 · US
2-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor anatgonists
US-2020289509-A1 · Sep 17, 2020 · US
3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides
US-2020283402-A1 · Sep 10, 2020 · US
2-phenylpyrimidine-4-carboxamides as ahr inhibitors
US-2020283395-A1 · Sep 10, 2020 · US
3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides
US-2020237757-A1 · Jul 30, 2020 · US
Means and methods for treating or diagnosing IDH1 R132H mutant-positive cancers
US-10161940-B2 · Dec 25, 2018 · US
Histone anti-cancer vaccines
US-2018155403-A1 · Jun 7, 2018 · US
Means and methods for treating or diagnosing idh1 r132h mutant-positive cancers
US-2015023991-A1 · Jan 22, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Deutsches Krebsforsch | 18 |
| Bayer Pharma AG | 14 |
| Bayer Ag | 12 |
| Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts | 2 |
| Univ Heidelberg | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 21 |
| A61K45/06 | 14 |
| C07D403/04 | 10 |
| C07D409/14 | 10 |
| C07D405/14 | 8 |